Project Grant HT9425261E044
- Federal Grant Award Summary Award: From Service to Survival: Investigating the Associations Between Military Deployment and Early-Onset Colorectal Cancer Mortality in Veterans Funding Agency: Defense Health Agency (DHA) Federal Program: Military Medical Research and Development (CFDA 12.420) Award Amount: $1.1 million Award Period: June 1, 2026 – May 31, 2030 Awardee: VA Connecticut Research & Education Foundation, Inc. This Project Grant supports a four-year research initiative to...
- Federal Project Grant Award Summary Yale University received a $1,009,054 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2029. The award supports research focused on the discovery and therapeutic targeting of endogenous retroviruses in clear cell renal cell carcinoma. This biomedical research initiative addresses cancer treatment through investigation of endogenous...
- Federal Grant Award Summary Health Research, Inc. received a $958,389 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2030. As the Roswell Park Division of Health Research, the organization will conduct advanced biomedical research at its Buffalo, New York location. Based on the awardee's established portfolio, the research is expected to advance healthcare solutions...
- The Defense Health Agency awarded a $1,412,826 Project Grant on September 1, 2023 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research through the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Identification of Risk and Early Detection Biomarkers for Liver Cancer," will support a 3-year study led by Dr. Towia Libermann at Bidmc, with a sub-award to Vanderbilt University Medical Center (VUMC) to assist with case...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Veterans Education and Research Association of Northern New England, Inc. (VERANNE) a $715,213 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2025, with an ultimate completion date of September 29, 2029. The grant funds a four-year research initiative investigating the use of bile acid-binding resins to decrease systemic per- and polyfluoroalkyl substance (PFAS)...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Bronx Veterans Medical Research Foundation, Inc. (BVMRF) a $1.96 million Project Grant on September 15, 2025, under the Military Medical Research and Development program (CFDA 12.420) to conduct a multimodal molecular study examining active pathophysiological pathways of blast injury and neurotrauma in military tactical training operations. The four-year award, with an ultimate completion date of September 14,...
- Federal Grant Award Summary The University of Connecticut Health Center received a $172,355 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2028. This award supports advanced biomedical research investigating spatial transcriptomic and proteomic shifts in tumor-infiltrating immunocytes to advance melanoma therapeutics. The research will leverage cutting-edge molecular...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. a Project Grant totaling $648,097 under the Military Medical Research and Development program (CFDA 12.420). The award, effective from September 1, 2025 through August 31, 2028, supports research investigating per- and polyfluoroalkyl substances (PFAS) and associated risks of thyroid cancer among active component service members of the U.S....
- Federal Grant Award Summary Yale University received a $1,008,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2029. The award funds a four-year research initiative titled "Discovery and Therapeutic Targeting of Endogenous Retroviruses in Clear Cell Renal Cell Carcinoma," to be conducted at the institution's Hamden, Connecticut location. This project...
The Defense Health Agency (DHA) awarded VA Connecticut Research & Education Foundation, Inc. a Project Grant totaling $516,256 under the Military Medical Research and Development program (CFDA 12.420) to conduct comprehensive risk stratification research for hepatocellular carcinoma in veterans living with chronic hepatitis B virus. The award, effective April 1, 2026, through March 31, 2029, supports a three-year research initiative based in West Haven, Connecticut, designed to develop and implement evidence-based risk assessment methodologies for identifying and stratifying veterans at elevated risk of hepatocellular carcinoma development. This research effort aligns with the Military Medical Research and Development program's mission to transform healthcare for service members and veterans through innovative biomedical research addressing critical health challenges. The project will advance clinical practice by establishing comprehensive risk stratification tools and protocols specific to the veteran population with chronic hepatitis B virus infection, potentially informing clinical decision-making, surveillance protocols, and intervention strategies for cancer prevention and early detection in this vulnerable population.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $516.3k | 3/12/26 |